Zinacef

Zinacef

cefuroxime

Manufacturer:

Sandoz

Distributor:

Sandoz
Concise Prescribing Info
Contents
Cefuroxime (tab: axetil; inj: Na)
Indications/Uses
Tab: URTI, lower resp tract, GUT, skin & soft tissue infections; gonorrhoea, acute uncomplicated gonococcal urethritis, & cervicitis; treatment of early & subsequent prevention of late Lyme disease in adults & childn ≥3 mth. Inj: Resp tract, ENT, UTI, soft-tissue, bone & joint, obstet & gynaecological infections; gonorrhoea; other infections including septicaemia, meningitis & peritonitis. Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal & vascular surgery. Prophylaxis in colonic or gynaecological surgery as monotherapy or may be used in combination w/ aminoglycoside antibiotic, or in conjunction w/ metronidazole (PO or by supp or inj).
Dosage/Direction for Use
Tab Adult Most infections, UTI, mild to moderate lower resp tract infections (eg, bronchitis), pyelonephritis 250 mg bid. More severe lower resp tract infections or pneumonia (if suspected) 500 mg bid. Uncomplicated gonorrhea 1 g as single dose. Adult & childn >12 yr Lyme disease 500 mg bid for 14 days. Sequential therapy: Pneumonia 1.5 g tid or bid (IV or IM) for 48-72 hr, followed by 500 mg bid for 7-10 days. Acute exacerbations of chronic bronchitis 750 mg tid or bid (IV or IM) for 48-72 hr, followed by 500 mg tid or bid for 5-10 days. Childn Most infections 125 mg bid. Otitis media or more severe infections 250 mg bid. <12 yr Lyme disease 250 mg bid for 14 days. Renal impairment CrCl ≥30 mL/min 125-500 mg bid; 10-29 mL/min Standard individual dose every 24 hr; <10 mL/min Standard individual dose every 48 hr. Inj Adult 750 mg tid by IM or IV. More severe infections 1.5 g tid IV. May be increased 6 hrly if necessary; total daily dose 3-6 g. Gonorrhea 1.5 g as single dose, given as 2 x 750 mg IM at different sites. Meningitis 3 g IV 8 hrly. Infant & childn 30-100 mg/kg/day 3-4 divided doses. 60 mg/kg/day is appropriate for most infections. Meningitis 150-250 mg/kg/day in 3-4 divided doses. Neonate 30-100 mg/kg/day as 2-3 divided doses. Meningitis 100 mg/kg/day IV. Surgical prophylaxis 1.5 g IV w/ induction of anesth for abdominal, pelvic & orthopedic operations; may be supplemented w/ two 750 mg IM doses 8 & 16 hr later. Cardiac, pulmonary, esophageal & vascular operations 1.5 g IV w/ induction of anesth continuing w/ 750 mg IM tid for a further 24-48 hr. Total joint replacement 1.5 g cefuroxime may be mixed dry w/ each pack of methyl methacrylate cement polymer before adding the liqd monomer. Renal impairment CrCl 10-20 mL/min 750 mg every bid, <10 mL/min 750 mg once daily. Patient on hemodialysis 750 mg IV or IM at the end of each dialysis. Patient w/ renal failure on continuous arteriovenous hemodialysis or high flux hemofiltration 750 mg bid.
Administration
Should be taken with food: Take after meals for better absorption. Do not crush.
Contraindications
Special Precautions
Patients who have experienced allergic reaction to penicillin or other β-lactams. Prolonged use may result to overgrowth of other nonsusceptible organisms (eg, enterococci & Clostridium difficile). Pseudomembranous colitis. Discontinue immediately if prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps. Pregnancy & lactation. Tab: Jarisch-Herxheimer reaction following treatment of Lyme disease. May impair ability to drive or operate machinery. Inj: Concurrent treatment at high dose w/ potent diuretics eg, furosemide or aminoglycosides. Renal impairment. Mild-to-moderate hearing loss in ped patients may occur.
Adverse Reactions
Eosinophilia; transient increases of hepatic enzyme levels. Tab: Overgrowth of Candida; headache, dizziness; GI disturbance including diarrhoea, nausea, abdominal pain. Inj: Neutropenia; inj site reactions eg, pain & thrombophlebitis.
Drug Interactions
Lower estrogen reabsorption & reduced efficacy of combined OCs. Tab: Lower bioavailability w/ drugs which reduce gastric acidity. False -ve result may occur in ferricyanide test. Inj: Slight interference w/ Cu reduction methods (Benedict's, Fehling's, Clinitest).
MIMS Class
Cephalosporins
ATC Classification
J01DC02 - cefuroxime ; Belongs to the class of second-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Zinacef inj 750 mg
Packing/Price
1's
Form
Zinacef tab 500 mg
Packing/Price
50's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in